Pitfalls of LC-MS/MS in the clinical laboratory

LC-MS in Drug Bioanalysis

Volumn 9781461438281, Issue , 2012, Pages 109-126

  Seger, Christoph ^a   Vogeser, Michael ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; IONS; LIQUID CHROMATOGRAPHY; PATIENT MONITORING; WELL TESTING;

ACHILLES' HEEL; ANALYTES; ANALYTICAL PROBLEMS; ION SUPPRESSION; ION YIELDS; LABORATORY MEDICINES; LC-MS-MS; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; SUPPRESSION EFFECTS; THERAPEUTIC DRUG MONITORING;

MASS SPECTROMETRY;

EID: 84949178879     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3828-1_5     Document Type: Chapter

References (70)

1. Vogeser M, Seger C (2008) A decade of HPLC-MS/MS in the routine clinical laboratory-goals for further developments. Clin Biochem 41:649-662
2. Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL (2009) A rapid HPLC-MS/MS method for the simultaneous quanti fication of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 4:526-534
3. Harms E, Olgemöller B (2011) Neonatal screening for metabolic and endocrine disorders. Dtsch Arztebl Int 108:11-22
4. Lehotay DC, Hall P, Lepage J, Eichhorst JC, Etter ML, Greenberg CR (2011) LC-MS/MS progress in newborn screening. Clin Biochem 44:21-31
5. Yang Z, Peng Y, Wang S (2005) Immunosuppressants: pharmacokinetics, methods of monitoring and role of high performance liquid chromatography/mass spectrometry. Clin Appl Immunol Rev 5:405-430
6. Seger C, Griesmacher A (2007) Some important aspects of implementing tandem mass spectrometry in a routine clinical laboratory environment. Biochem Med 17:29-51
7. Mauerer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315-1325
8. Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54-65
9. Kamel A, Prakash C (2006) High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology. Curr Drug Metab 7:837-852
10. Stokvis E, Rosing H, Beijnen JH (2005) Liquid chromatography-mass spectrometry for the quantitative bioanalysis of anticancer drugs. Mass Spectrom Rev 24:887-917
11. Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243-265
12. Vogeser M, Parhofer KG (2007) Liquid chromatography tandem-mass spectrometry (LC-MS/MS) - technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115:555-570
13. Kushnir MM, Rockwood AL, Bergquist J (2010) Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrom Rev 29:480-502
14. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle W (2011) Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 44:77-88
15. Hoofnagle AN (2010) Quantitative clinical proteomics by liquid chromatography-tandem mass spectrometry: assessing the platform. Clin Chem 56:161-164
16. Hortin GL (2005) Can mass spectrometric protein pro filing meet desired standards of clinical laboratory practice? Clin Chem 51:3-5
17. Carr SA, Anderson L (2008) Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin Chem 54:1749-1752
18. Anderson NL (2010) The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56:177-185
19. Hoofnagle AN, Wener MH (2009) The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods 347:3-11
20. Hortin GL, Carr SA, Anderson NL (2010) Introduction: advances in protein analysis for the clinical laboratory. Clin Chem 56:159-161
21. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM et al (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 27:633-641
22. Anderson L, Hunter CL (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5:573-588
23. Kumar V, Barnidge DR, Cheng LS, Twentyman JM, Cradic KW, Grebe SK, Singh RJ (2010) Quanti fication of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 56:306-313
24. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW (2008) Quanti fication of thyroglobulin, a low-abundance serum protein, by immunoaf finity peptide enrichment and tandem mass spectrometry. Clin Chem 54:1796-1804
25. Rodriguez-Cabaleiro D, Van Uytfanghe K, Stove V, Fiers T, Thienpont LM (2007) Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography/tandem mass spectrometry. Clin Chem 53:1462-1469
26. Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN (2007) Quanti fication of hemoglobin A2 by tandem mass spectrometry. Clin Chem 53:1448-1454
27. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG (2007) LC-MS/MS quanti fication of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 53:673-678
28. Rauh M, Gröschl M, Rascher W (2007) Simultaneous quanti fication of ghrelin and desacylghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin Chem 53:902-910
29. Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E et al (2009) Quanti fication of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 8:2339-2349
30. Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT et al (2009) Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaf finity enrichment and targeted mass spectrometry. Clin Chem 55:1108-1117
31. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA (2007) Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 6:2212-2229
32. Vogeser M, Seger C (2010) Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 56:1234-1244
33. Allen KR (2006) Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine. Clin Toxicol 44:147-153
34. Vogeser M, Zachoval R, Spöhrer U, Jacob K (2001) Potential lack of speci ficity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit 23:722-724
35. Vogeser M, Spöhrer U (2005) Pitfall in the high-throughput quanti fication of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 43:400-402
36. Singh RJ (2008) Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem 54:221-223
37. Carter GD, Jones JC (2009) Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 46:79-81
38. Carter GD (2009) 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 55:1300-1302
39. Kebarle P, Verkerk UH (2009) Electrospray: from ions in solution to ions in the gas phase, what we know now. Mass Spectrom Rev 28:898-917
40. Covey TR, Thomson BA, Schneider BB (2009) Atmospheric pressure ion sources. Mass Spectrom Rev 28:870-897
41. Lagerwerf FM, Van Dongen WD, Steenvoorden RJJM, Honing M, Jonkman JHG (2000) Exploring the boundaries of bioanalytical quantitative LC-MS-MS. Trends Anal Chem 19:418-427
42. Annesley TM (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041-1044
43. Taylor PJ (2005) Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38:328-334
44. Keller BO, Sui J, Young AB, Whittal RM (2008) Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta 627:71-81
45. Guo X, Bruins AP, Covey TR (2006) Characterization of typical chemical background interferences in atmospheric pressure ionization liquid chromatography-mass spectrometry. Rapid Commun Mass Spectrom 20:3145-3150
46. Gustavsson E, Andersson M, Stephanson N, Beck O (2007) Validation of direct injection electrospray LC-MS/MS for con firmation of opiates in urine drug testing. J Mass Spectrom 42:881-889
47. Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC et al (2008) Stateof-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 54:1290-1297
48. Wang S, Cyronak M, Yang E (2007) Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J Pharm Biomed Anal 43:701-707
49. Lindegardh N, Annerberg A, White NJ, Day NP (2008) Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 862:227-236
50. Stokvis E, Rosing H, Beijnen JH (2005) Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 19:401-407
51. Sauvage FL, Stanke-Labesque F, Gagnieu MC, Jourdil JF, Babany G, Marquet P (2009) Feasibility of ribavirin therapeutic drug monitoring in hepatitis C. Ther Drug Monit 31:374-381
52. Vogeser M (2008) Instrument-speci fic matrix effects of calibration materials in the LC-MS/MS analysis of tacrolimus. Clin Chem 54:1406-1408
53. Yan Z, Caldwell GC, Jones WJ, Masucci JA (2006) Cone voltage induced in-source dissociation of glucuronides in electrospray and implications in biological analyses. Rapid Commun Mass Spectrom 17:1433-1442
54. Sherman J, McKay MJ, Ashman K, Molloy MP (2009) How speci fic is my SRM? The issue of precursor and product ion redundancy. Proteomics 9:1120-1123
55. Careri M, Mangia A (2006) Validation and quali fication: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal Bioanal Chem 386:38-45
56. Rauh M, Gröschl M, Rascher W, Dörr HG (2006) Automated, fast and sensitive quanti fication of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids 71:450-458
57. Carvalho VM, Nakamura OH, Vieira JG (2008) Simultaneous quantitation of seven endogenous C-21 adrenal steroids by liquid chromatography tandem mass spectrometry in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 872:154-161
58. Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, Csaszar E, Köfeler HC (2009) On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study. J Mass Spectrom 44:485-493
59. Hopley C, Bristow T, Lubben A, Simpson A, Bull E, Klagkou K, Herniman J, Langley J (2008) Towards a universal product ion mass spectral library - reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun Mass Spectrom 22:1779-1786
60. Kaufmann A, Butcher P, Maden K, Widmer M, Giles K, Uria D (2009) Are liquid chromatography/electrospray tandem quadrupole fragmentation ratios unequivocal con firmation criteria? Rapid Commun Mass Spectrom 23:985-998
61. Kind T, Fiehn O (2006) Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinform 7:234
62. Mylonas R, Mauron Y, Masselot A, Binz PA, Budin N, Fathi M et al (2009) X-Rank: a robust algorithm for small molecule identi fication using tandem mass spectrometry. Anal Chem 81:7604-7610
63. Steimer W (1999) Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how speci fic is speci fic? Clin Chem 45:371-381
64. Schütz E, Svinarov D, Shipkova M, Niedmann PD, Armstrong VW, Wieland E et al (1998) Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 44:2158-2164
65. Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A et al (2007) ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357:2562-2575
66. Srinivas TR, Meier-Kriesche HU (2008) Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol 3:S101-S116
67. Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J (2004) Rapid simultaneous quanti fication of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 346:181-190
68. Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL (2009) A rapid HPLC-MS/MS method for the simultaneous quanti fication of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 4:526-534
69. Seger C, Vogeser M (2010) Immunosuppressant drug monitoring - a routine undertaking? J Lab Med 34:117-124
70. Holt D, Moreton M, Laamanen K, Johnston A (2005) A microparticle enzyme immunoassay to measure sirolimus. Transplant Proc 37:182-184